Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL712894 | 1.00 | PRKCA (0.38) | PRKCAELANEHTT | |
| SCHEMBL3307099 | 1.00 | PRKCA (0.38) | PRKCAELANEHTT | |
| SCHEMBL11433341 | 0.82 | PRKCA (0.36) | PRKCAELANE | |
| SCHEMBL3849343 | 0.79 | PRKCA (0.38) | PRKCAELANE | |
| SCHEMBL65267 | 0.76 | ELANE (0.40) | PRKCAELANE | |
| SCHEMBL493899 | 0.75 | PRKCA (0.35) | PRKCAELANE | |
| Ammonia Solution, Strong SCHEMBL25421893 | 0.74 | ELANE (0.39) | PRKCAELANE | |
| SCHEMBL7026388 | 0.74 | ELANE (0.39) | PRKCAELANE | |
| SCHEMBL13050551 | 0.73 | PRKCA (0.42) | PRKCA | |
| SCHEMBL6497837 | 0.73 | CA2 (0.41) | PRKCAELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2132179-B1 | PROCESS FOR PREPARING ISOMERS OF CARMOTEROL | CIPLA LTD (IN) | 2012-08-08 | — | — | EP | claimed |
| US-8236959-B2 | Process for preparing isomers of carmoterol | CIPLA LIMITED (IN) | 2012-08-07 | — | — | US | claimed |
| US-20100113790-A1 | Process for Preparing Isomers of Carmoterol | CIPLA LIMITED (IN) | 2010-05-06 | — | — | US | claimed |
| EP-2132179-A1 | PROCESS FOR PREPARING ISOMERS OF CARMOTEROL | Cipla Limited (IN) | 2009-12-16 | — | — | EP | claimed |
| WO-2008104781-A1 | PROCESS FOR PREPARING ISOMERS OF CARMOTEROL | CIPLA LIMITED (IN) | 2008-09-04 | — | — | WO | claimed |
| EP-2132179-B1 | PROCESS FOR PREPARING ISOMERS OF CARMOTEROL | CIPLA LTD (IN) | 2012-08-08 | — | — | EP | disclosed |
| US-8236959-B2 | Process for preparing isomers of carmoterol | CIPLA LIMITED (IN) | 2012-08-07 | — | — | US | disclosed |
| US-20100113790-A1 | Process for Preparing Isomers of Carmoterol | CIPLA LIMITED (IN) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113790-A1 | Process for Preparing Isomers of Carmoterol | NR1H2, NR1H3, ADRB1 | PRKCA 2863/4885ELANE 4100/4885HTT 3891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.